These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 26676289)
1. Urinary Nerve Growth Factor Levels in Urinary Tract Diseases With or Without Frequency Urgency Symptoms. Kuo HC; Liu HT; Tyagi P; Chancellor MB Low Urin Tract Symptoms; 2010 Sep; 2(2):88-94. PubMed ID: 26676289 [TBL] [Abstract][Full Text] [Related]
2. Promise of Urinary Nerve Growth Factor for Assessment of Overactive Bladder Syndrome. Kuo HC; Liu HT; Guan Z; Tyagi P; Chancellor MB Low Urin Tract Symptoms; 2011 Apr; 3(1):2-9. PubMed ID: 26676344 [TBL] [Abstract][Full Text] [Related]
3. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Liu HT; Lin H; Kuo HC Neurourol Urodyn; 2011 Nov; 30(8):1525-9. PubMed ID: 21826717 [TBL] [Abstract][Full Text] [Related]
4. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment. Liu HT; Kuo HC Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272 [TBL] [Abstract][Full Text] [Related]
5. Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders. Liu HT; Chen CY; Kuo HC J Formos Med Assoc; 2010 Dec; 109(12):862-78. PubMed ID: 21195884 [TBL] [Abstract][Full Text] [Related]
6. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention. Liu HT; Kuo HC Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891 [TBL] [Abstract][Full Text] [Related]
7. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Yokoyama T; Kumon H; Nagai A Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444 [TBL] [Abstract][Full Text] [Related]
8. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence. Kuo HC; Liu HT; Chancellor MB Neurourol Urodyn; 2010 Mar; 29(3):482-7. PubMed ID: 19367641 [TBL] [Abstract][Full Text] [Related]
9. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. Liu HT; Chancellor MB; Kuo HC BJU Int; 2009 Jun; 103(12):1668-72. PubMed ID: 19220267 [TBL] [Abstract][Full Text] [Related]
10. Urinary nerve growth factor correlates with the severity of urgency and pain. Kim SW; Im YJ; Choi HC; Kang HJ; Kim JY; Kim JH Int Urogynecol J; 2014 Nov; 25(11):1561-7. PubMed ID: 24866276 [TBL] [Abstract][Full Text] [Related]
11. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. Liu HT; Tyagi P; Chancellor MB; Kuo HC BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864 [TBL] [Abstract][Full Text] [Related]
12. Potential Biomarkers Utilized to Define and Manage Overactive Bladder Syndrome. Kuo HC Low Urin Tract Symptoms; 2012 Mar; 4 Suppl 1():32-41. PubMed ID: 26676698 [TBL] [Abstract][Full Text] [Related]
13. NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome. Kim SR; Moon YJ; Kim SK; Bai SW Yonsei Med J; 2015 Jan; 56(1):204-11. PubMed ID: 25510766 [TBL] [Abstract][Full Text] [Related]
14. Urinary nerve growth factor could be a biomarker for interstitial cystitis/painful bladder syndrome: a meta-analysis. Qu HC; Zhang W; Yan S; Liu YL; Wang P PLoS One; 2014; 9(9):e106321. PubMed ID: 25181532 [TBL] [Abstract][Full Text] [Related]
15. [Nerve growth factor as a biomarker in the diagnosis and treatment of overactive bladder (OAB)]. Jankiewicz K; Kulik-Rechberger B; Nowakowski Ł; Rechberger T Ginekol Pol; 2012 Jul; 83(7):532-6. PubMed ID: 22880479 [TBL] [Abstract][Full Text] [Related]
16. Urinary nerve growth factor in women with overactive bladder syndrome. Liu HT; Chen CY; Kuo HC BJU Int; 2011 Mar; 107(5):799-803. PubMed ID: 20804479 [TBL] [Abstract][Full Text] [Related]
17. The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding. Ergin G; Kibar Y; Ebiloğlu T; Irkılata HC; Kopru B; Kaya E; Uyanık M; Tapan S; Dayanc MM J Pediatr Urol; 2016 Apr; 12(2):118.e1-6. PubMed ID: 26701107 [TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)? Seth JH; Sahai A; Khan MS; van der Aa F; de Ridder D; Panicker JN; Dasgupta P; Fowler CJ BJU Int; 2013 Mar; 111(3):372-80. PubMed ID: 23444927 [TBL] [Abstract][Full Text] [Related]
19. Urinary Nerve Growth Factor Can Predict Therapeutic Efficacy in Children With Overactive Bladder. Fukui S; Aoki K; Morizawa Y; Miyake M; Fujimoto K Urology; 2017 May; 103():214-217. PubMed ID: 28161379 [TBL] [Abstract][Full Text] [Related]
20. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis. Sheng W; Zhang H; Ruth KH Neurourol Urodyn; 2017 Sep; 36(7):1703-1710. PubMed ID: 28102552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]